In this week’s Homerun Slides set, we look at Dr. Stanley Schwartz’s presentation from this year’s ADA with his groundbreaking proposal to classify diabetes using a ‘Beta-cell Centric’ approach….

Rudy Bilous, MD, FRCP Richard Donnelly, MD, PHD, FRCP, FRACP   Epidemiological studies of diabetes prevalence are often based upon age and self-reported diagnosis. Consequently differentiating type 1 and type 2 patients in population studies is difficult. The most recent authoritative review of global prevalence published by the International Diabetes Federation (IDF) …

For years we have had methods for titrating patients with long-acting insulin and there have been very successful patient self-titration algorithms that have proven to work as well as physician-directed dosing. The problem has always been what to do when we need to begin mealtime insulin. Since the use of …

The First Randomized Trial Comparing Two Patient-driven Approaches to Initiate and Titrate Prandial Insulin Lispro in Type 2 Diabetes In this Homerun Slides series, courtesy of Dr. Steven Edelman, on the AUTONOMY Trial we get an inside look at the groundbreaking results and conclusions that can be drawn from the patient driven …

Steve, Andrew and I are at the AADE Annual Meeting in Orlando. This meeting has a different flavor than some of the other meetings that we report on. While there are many clinical studies and new drug discoveries presented at the ADA and IDF Scientific Sessions, the AADE meeting is …

BD AutoShield Duo Pen Needle  The BD AutoShield Duo Pen Needle automatically protects patients from both ends of a pen needle which become contaminated after use. This prevents used needle exposure for anyone who may come into contact after the pen needle is removed from the pen. The small 5mm …

A study found short bursts of fast walking resulted in better blood glucose control than did walking at a steady pace. Data on participants aged 57 to 61 revealed that only the interval walkers achieved a reduction in glucose levels at four months, while the control group and those who …

Men showed slightly greater hip-bone loss at four years than did those in the diabetes support and education cohort. However, researchers did not observe a similar trend in women with diabetes. The trial randomized 1,309 overweight and obese individuals with type 2 diabetes to an intensive lifestyle intervention (ILI) versus …

After revascularization procedures, the risk for total mortality, cardiovascular mortality and myocardial infarction is highest among patients with low BMI, according to research. Similarly, CV mortality was lowest among overweight patients in the meta-analysis conducted by Abhishek Sharma, MD, of the Maimonides Medical Center, Brooklyn, N.Y., and colleagues, who looked …

Metformin and SGLT2 inhibitors together reduce the blood sugar levels of diabetics more effectively than either drug alone….